Enrofloxacin Shifts Intestinal Microbiota and Metabolic Profiling and Hinders Recovery
Total Page:16
File Type:pdf, Size:1020Kb
bioRxiv preprint doi: https://doi.org/10.1101/2020.07.13.201830; this version posted July 14, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Enrofloxacin shifts intestinal microbiota and metabolic profiling and hinders recovery 2 from Salmonella enterica subsp. enterica serovar Typhimurium infection in neonatal 3 chickens 4 5 Boheng Ma,a,b,c,& Xueran Mei,a,b,c,& Changwei Lei,a,b,c Cui Li,a,b,c Yufeng Gao,a,b,c Linghan 6 Kong,a,b,c Xiwen Zhai,a,b,c,d Hongning Wanga,b,c,# 7 8 a College of Life Sciences, Sichuan University, Chengdu, People’s Republic of China 9 b Key Laboratory of Bio-Resource and Eco-Environment of Ministry of Education, Chengdu, 10 People’s Republic of China 11 c Animal Disease Prevention and Food Safety Key Laboratory of Sichuan Province, Chengdu, 12 People’s Republic of China 13 d Sichuan Water Conservancy Vocational Collage, Chengdu, People’s Republic of China 14 15 Running head: Effects of enrofloxacin on chickens 16 17 # Address correspondence to Hongning Wang, [email protected] 18 & Both authors are identified as Co-First Author. 19 20 Word count: 211 words (Abstract); 4895 words (main text) 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.07.13.201830; this version posted July 14, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 21 ABSTRACT 22 Enrofloxacin is an important antibiotic used for prevention and treatment of Salmonella infection 23 in poultry in many countries. However, oral administration of enrofloxacin may lead to the 24 alterations in the microbiota and metabolome in the chicks intestine, thereby reducing 25 colonization resistance to the Salmonella infection. To study the effects of enrofloxacin on 26 chicken cecal Salmonella, we used different concentrations of enrofloxacin to feed 1-day-old 27 chickens, followed by oral challenge with Salmonella enterica subsp. enterica serovar 28 Typhimurium (S. Typhimurium). We then explored the distribution patterns of S. Typhimurium in 29 vivo in intestinal contents using quantitative polymerase chain reaction and microbial 16S 30 amplicon sequencing on days 7, 14, and 21. Metabolome sequencing was used to explore the gut 31 metabolome on day 14. Faecalibacterium and Anaerostipes, which are closely related to the 32 chicken intestinal metabolome, were screened using a multi-omics technique. The abundance of 33 S. Typhimurium was significantly higher in the enrofloxacin-treated group than in the untreated 34 group, and S. Typhimurium persisted longer. Moreover, the cecal colony structures of the three 35 groups exhibited different characteristics, with Lactobacillus reaching its highest abundance on 36 day 21. Notably, S. Typhimurium infection is known to affect the fecal metabolome of chickens 37 differently. Thus, our results suggested that enrofloxacin and Salmonella infections completely 38 altered the intestinal metabolism of chickens. 39 40 KEYWORDS gut microbiota, enrofloxacin, metabolome, chicken, Salmonella Typhimurium 41 2 bioRxiv preprint doi: https://doi.org/10.1101/2020.07.13.201830; this version posted July 14, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 42 IMPORTANCE 43 In this study, we examined the effects of S. Typhimurium infection and enrofloxacin treatment on 44 the microbial flora and metabolite synthesis in chicken guts in order to identify target metabolites 45 that may cause S. Typhimurium colonization and severe inflammation and to evaluate the 46 important flora that may be associated with these metabolites. Our findings may facilitate the use 47 of antibiotics to prevent S. Typhimurium infection. 3 bioRxiv preprint doi: https://doi.org/10.1101/2020.07.13.201830; this version posted July 14, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 48 INTRODUCTION 49 Foodborne diseases are associated with high morbidity and mortality rates worldwide and pose 50 major challenges to food safety and economics (1). Salmonella is an important foodborne 51 pathogen of the family Enterobacteriaceae. This pathogen causes millions of infections 52 worldwide each year, both in humans and livestock. Salmonella has been shown to cause 53 intestinal inflammation and barrier dysfunction in chickens, thereby affecting chicken 54 performance (2). Currently, more than 2,600 serotypes of Salmonella are known, with varying 55 pathogenicity and host specificity. Salmonella enterica subsp. enterica serovar Typhimurium (S. 56 Typhimurium) is a typical representative of non-host-specific Salmonella found in poultry. 57 The main route of infection with Salmonella in poultry is the fecal-oral route. For 58 multiserotype infections, bacteria mainly colonize in the ceca of poultry. After colonizing the 59 intestines, these bacteria invade the intestinal epithelial cells and dendritic cells and reach the 60 submucosa to be phagocytosed by macrophages. The bacteria then replicate in and colonize the 61 spleen and liver, causing systemic infections mediated by bacterium/macrophage interactions (3, 62 4). In mice infected with Salmonella, macrophages produce IL-12 and IL-18 and promote IFN-γ 63 secretion by natural killer (NK) cells (5). 64 Owing to the widespread use of antibiotics in agriculture and animal husbandry, 65 Salmonella resistance has rapidly increased. In 2013, China alone consumed approximately 66 927,000 tons of antibiotics (6). Moreover, the consumption of antibiotics as veterinary drugs 67 increased from 46% to 52% between 2007 and 2013. Enrofloxacin, florfenicol, lincomycin, and 68 amoxicillin are among the most commonly consumed veterinary antibiotics in China (7). 69 Enrofloxacin is the main antibiotic used for treating Salmonella infection in poultry in many 4 bioRxiv preprint doi: https://doi.org/10.1101/2020.07.13.201830; this version posted July 14, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 70 countries, and the concentration of enrofloxacin in chicken manure in China was found to be 71 1,421 mg/kg (8). 72 Quinolones, such as enrofloxacin, affect the composition and number of bacterial species 73 in the chicken gut (9), thereby altering resistance to pathogen invasion. Indeed, bacteria residing 74 in the gut can mediate the colonization of S. Typhimurium in the body by producing short-chain 75 fatty acids (SCFAs), such as propionic acid, which inhibits S. Typhimurium growth by 76 influencing the intracellular pH (10). By producing SCFAs, lactic acid bacteria inhibit 77 Salmonella colonization in the colon and jejunum, accelerate Salmonella clearance from stools, 78 and reduce Salmonella transfer from the small intestine to the spleen (11). The concentrations of 79 SCFAs and butyric acid are inversely proportional to the degree of inflammation (12). 80 Some Enterobacteriaceae in the normal gut flora can mediate Salmonella multiplication 81 through competition for oxygen (13). Additionally, antibiotics reduce the number of butyrate- 82 producing Clostridium perfringens in the intestinal flora, shifting the host cells from oxidative 83 metabolism to lactic acid fermentation and increasing the level of lactic acid in the intestine; 84 Salmonella then gain a colonization advantage by using lactic acid (14). Intestinal metabolism is 85 also affected by the gut flora composition. Using antibiotics increases fucose and sialic acid 86 contents in the intestine, thereby affecting Salmonella and C. difficile colonization (15, 16). 87 Similarly, antibiotics also decrease the levels of secondary bile acids in the intestine and inhibit 88 C. difficile colonization (16). 89 Accordingly, in this study, we investigated the effects of enrofloxacin on Salmonella 90 colonization in chickens and the relationship between intestinal flora and Salmonella 91 colonization. We also evaluated changes in microbial metabolites in the ceca of enrofloxacin- 5 bioRxiv preprint doi: https://doi.org/10.1101/2020.07.13.201830; this version posted July 14, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 92 treated chickens infected with Salmonella and used multiomics association analyses to determine 93 the correlations between microbial community structure and microbial metabolites. 94 6 bioRxiv preprint doi: https://doi.org/10.1101/2020.07.13.201830; this version posted July 14, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 95 RESULTS 96 Response of Salmonella to enrofloxacin 97 First, S. Typhimurium abundance in the samples was evaluated. S. Typhimurium was not isolated 98 from C1, C2, or C3 groups. On day 7, the highest abundance of S. Typhimurium was found in the 99 cecum contents of group E1 (6.128 log10CFU/g), followed by that of groups E3 and (5.090 and 100 3.945 log10CFU/g, respectively; P < 0.001). The abundances of S. Typhimurium in the heart, 101 liver, and spleen of group E1 were significantly higher than those in the other two groups (P < 102 0.001). On day 14, the abundance of S. Typhimurium in group E1 (3.371 log10CFU/g) was 103 significantly lower than those in groups E2 (4.829 log10CFU/g) and E3 (4.366 log10CFU/g; P < 104 0.01). Moreover, the abundances of S. Typhimurium were significantly lower in heart, liver, and 105 spleen samples from group E1 than those from groups E2 and E3, except for heart samples from 106 group E3. On day 21, the relative abundances of S. Typhimurium were 3.170, 5.146, and 5.636 107 log10CFU/g in groups E1, E2, and E3, respectively; that in group E1 was significantly lower than 108 those in the other two groups.